STROKE in young adults nearly doubled throughout multiple decades while cardiovascular comorbidities and substance use accelerated. Population-based data from the Greater Cincinnati and Northern Kentucky Stroke Study demonstrated that first-ever stroke incidence among individuals aged 20 to 54 surged from 33.90 cases per 100,000 person-years in 1993 and 1994 to 62.18 cases per 100,000 person-years in 2020. This alarming upward trajectory contrasted sharply with trends observed in adults aged 55 and older, who experienced a significant decline from 618.78 to 453.04 cases per 100,000 person-years over the same evaluation period.
The temporal surge in young patients was driven predominantly by ischemic stroke, which nearly doubled from 23.83 to 47.28 cases per 100,000 person-years. Among adjudicated ischemic stroke mechanisms, cardioembolic stroke demonstrated a notable increase from 10.46% to 18.48%, whereas large vessel disease trended downward. Subarachnoid hemorrhage and intracerebral hemorrhage incidence rates remained largely stable across the study cohorts.
Concurrently, documented cardiovascular comorbidities increased substantially among young stroke cases. Hypertension prevalence climbed from 47.27% to 60.29%, diabetes rose from 19.09% to 25.49%, and atrial fibrillation increased from 1.36% to 5.88%. Documented substance use exhibited an extraordinary escalation, rising from 4.55% in 1993 to 40.20% in 2020, with marijuana use accounting for the vast majority of this increase. Although magnetic resonance imaging utilization grew from 32.73% to 79.17%, investigators determined that heightened neuroimaging alone could not explain the rising incidence.
Despite rising incidence, adjusted 30-day case fatality rates among young adults declined modestly from 11.7% to 9.4%. This survival benefit was concentrated primarily within hemorrhagic subtypes, including intracerebral hemorrhage, which fell from 27.5% to 21.2%. Greater admission to specialized neurologic intensive care units likely contributed to these short-term gains. Because younger patients are surviving acute events at higher rates amidst rising incidence, clinicians face an expanding cohort living with long-term neurological disability. These trends reinforce the pressing need for aggressive vascular risk screening and primary prevention in early adulthood.
Reference
Fisher ER et al. Stroke in the Young: Incidence, 30-Day Case Fatality Rates, and Risk Factors Over Time in a Population-Based Study. Neurology. 2026;107(8):e218622.
Studio Romantic on adobe stock
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
